January 21, 2026
Company Name: Japan Lifeline Co., Ltd.
Representative: Keisuke Suzuki, President and CEO
(Security Code: 7575; TSE Prime Market)
Inquiries: Takeyoshi Egawa, Director and CFO
(TEL. +81-3-6711-5200)
Japan Lifeline Updates Investors GuideJapan Lifeline Co., Ltd. ("Japan Lifeline") today announced the publication of its "Investors Guide (December 2025)" on the company website.
Japan Lifeline, as a medical device company with distinctive technologies and products, aims to provide investors with decision-useful information through clear explanations of its business operations and growth strategies. The guide offers a systematic overview, supported by charts and figures, of the company's business model, market
environment, competitive advantages, and growth initiatives.
Japan Lifeline considers the Investor Guide to be one of its most valuable tools for providing up-to-date information to investors. The company plans to update the guide semi-annually, with the next update scheduled for around June 2026.
The Investor Guide is available at: https://www.japanlifeline.com/investors/news/index.html (The PDF is available in the IR News section of our website.)
The company remains committed to enhancing its disclosure practices and promoting constructive dialogue with investors.
Investors Guide (December 2025) Table of Contents